Dr. Albert L. Lin, M.D.
Retina Specialist (Retina Specialist (Ophthalmology) Physician)
- Medicare participating
At a glance
- Medical school
- University of Mississippi School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 871
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: University of Mississippi School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Retina Specialist (Ophthalmology) Physician primary
MS license 23365
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Mississippi Med Center Jackson, MS
Medical groups
- State of Mississippi - University of Mississippi Medical Center (965 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 871
- Services billed
- 18,403
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 8,460 | 33 |
| Imaging of retina | 1,663 | 763 |
| Established patient complete exam of visual system | 677 | 529 |
| Injection, aflibercept, 1 mg | 668 | 99 |
| Injection of drug into eye | 617 | 167 |
| Established patient office or other outpatient visit, 20-29 minutes | 481 | 261 |
| Established patient office or other outpatient visit, 30-39 minutes | 347 | 213 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 210 | 17 |
| Compounded drug, not otherwise classified | 145 | 59 |
| Photography of the retina | 99 | 65 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Jackson, MS | 150 |
| Prednisolone Acetate Other prescribers in Jackson, MS | 138 |
| Latanoprost Other prescribers in Jackson, MS | 102 |
| Brimonidine Tartrate Other prescribers in Jackson, MS | 84 |
| Ketorolac Tromethamine Other prescribers in Jackson, MS | 53 |
| Methotrexate (methotrexate sodium) Other prescribers in Jackson, MS | 40 |
| Atropine Sulfate | 17 |
| Combigan (brimonidine tartrate/timolol) Other prescribers in Jackson, MS | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $99.62 in total to this clinician.
| Genentech USA, Inc. | $46.98 |
|---|---|
| Astellas Pharma US Inc | $29.28 |
| Apellis Pharmaceuticals, Inc. | $23.36 |
| Food and Beverage | $99.62 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $43,665 in research payments for these studies, mostly to the institutions running them.
- A 96-week, Two-arm, Randomized, Single-masked, Multi-center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic…
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.